Search

Your search keyword '"Hotta, K"' showing total 2,390 results

Search Constraints

Start Over You searched for: Author "Hotta, K" Remove constraint Author: "Hotta, K"
2,390 results on '"Hotta, K"'

Search Results

2. Final overall survival analysis from the phase III J-ALEX study of alectinib versus crizotinib in ALK inhibitor-naïve Japanese patients with ALK-positive non-small-cell lung cancer

3. Durvalumab, with or without tremelimumab, plus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer: 3-year overall survival update from CASPIAN

5. Supine Cycling Exercise Enhances Cerebral Oxygenation of Motor-Related Areas in Healthy Male Volunteers

6. Effects of 20-Minute Intensive Exercise on Subjects with Different Working Memory Bases

7. Cerebral Oxygenation Dynamics During Incremental Exercise: Comparison of Arm Cranking and Leg Cycling

10. The CFT-interpolating Black Hole in Three Dimensions

18. Cisplatin-induced hyponatremia in malignancy: comparison between brand-name and generic formulation

19. Study design and patient recruitment for the Japan Polyp Study

20. 1530P Durvalumab (D) + platinum-etoposide (EP) in first-line extensive-stage SCLC (ES SCLC): Effect of age and platinum agent on outcomes in CASPIAN

21. EP.06B.04 Aging Alteration of Biomarkers and Its Prognostic Role in Elderly Lung Cancer Patients Treated with Adjuvant S-1 Chemotherapy

23. Corrigendum to ‘Gefitinib induction followed by chemoradiotherapy in EGFR-mutant, locally advanced non-small-cell lung cancer: LOGIK0902/OLCSG0905 phase II study’: [ESMO Open Volume 6, Issue 4, August 2021, 100191]

27. Corrigendum to ‘Gefitinib induction followed by chemoradiotherapy in EGFR-mutant, locally advanced non-small-cell lung cancer: LOGIK0902/OLCSG0905 phase II study’

28. Hippocampal Sparing Radiotherapy in adults with Primary Brain Tumors: A comparative planning and dosimetric study using IMPT, IMRT and 3DCRT

29. First-line nivolumab + ipilimumab in advanced NSCLC : CheckMate 227 subpopulation analyses in Asian patients

30. First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in advanced non-small cell lung cancer: a subanalysis of Asian patients in CheckMate 9LA

32. Durvalumab+ Tremelimumab + Platin-Etoposide in first-line extensive-stage SCLC (ES-SCLC): 36-month Overall Survival from the Phase 3 CASPIAN study

33. 141O Durvalumab (D) ± tremelimumab (T) + platinum-etoposide (EP) in 1L extensive-stage (ES) SCLC: Characteristics of long-term survivors in the CASPIAN study

34. Successful Treatment of Metastatic Urothelial Carcinoma after Accurate Diagnosis by Immunohistochemistry

35. Surgically induced necrotizing scleritis after primary pterygium surgery with conjunctival autograft

37. LBA61 Durvalumab ± tremelimumab + platinum-etoposide in first-line extensive-stage SCLC (ES-SCLC): 3-year overall survival update from the phase III CASPIAN study

38. Association of genetic variation in FTO with risk of obesity and type 2 diabetes with data from 96,551 East and South Asians

42. Response to Steroid and Immunosuppressive Therapies May Predict Post-transplant Recurrence of Focal Segmental Glomerulosclerosis

47. Artificial Intelligence-Assisted Colonoscopy for Cancer Recognition: A Multicenter Study Designed to Obtain Regulatory Approval

Catalog

Books, media, physical & digital resources